2013 AAFP Feline Vaccination Advisory Panel Report

Journal of Feline Medicine and Surgery

Volumn 15, Issue 9, 2013, Pages 785-808

  Scherk, Margie A ^a   Ford, Richard B ^b   Gaskell, Rosalind M ^c   Hartmann, Katrin ^d   Hurley, Kate F ^e   Lappin, Michael R ^f   Levy, Julie K ^g   Little, Susan E ^h   Nordone, Shila K ^b   Sparkes, Andrew H ⁱ  

^a CatsINK   (Canada)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Veterinary Dentistry and Oral Surgery   (United States)

^g University of Florida   (United States)

^h Bytown Cat Hospital   (Canada)

ⁱ ISFM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HEALTH CARE PLANNING; INFECTION CONTROL; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; STANDARD; VACCINATION; VETERINARY MEDICINE;

ANIMALS; CAT DISEASES; CATS; COMMUNICABLE DISEASE CONTROL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GUIDELINES AS TOPIC; HEALTH PLANNING GUIDELINES; SOCIETIES, MEDICAL; VACCINATION; VETERINARY MEDICINE;

EID: 84882949239     PISSN: 1098612X     EISSN: 15322750     Source Type: Journal    
DOI: 10.1177/1098612X13500429     Document Type: Article

References (76)

1. Richards JR,Elston TH,Ford RB,Gaskell RM,Hartmann K,Hurley KF, et al.The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel Report.J Am Vet Med Assoc. 2006;229:1405-1441.
2. Vogt AH,Rodan I,Brown M,Brown S,Buffington CAT,LaRue Forman MJ, et al.AAFP-AAHA: Feline life stage guidelines.J Feline Med Surg. 2010;12:43-54.
3. Day MJ,Schultz RDVeterinary immunology - principles and practice. London: Mason Publishing; 2011:192-202.
4. Moore GE,DeSantis-Kerr AC,Guptill LF,Glickman NW,Lewis HB,Glickman LT.Adverse events after vaccine administration in cats: 2560 cases (2002-2005).J Am Vet Med Assoc. 2007;231:94-100.
5. Lappin MR,Veir J,Hawley J.Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.J Feline Med Surg. 2009;11:159-162.
6. Lappin MR,Sebring RW,Porter M,Radecki SJ,Veir J.Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1.J Feline Med Surg. 2006;8:158-163.
7. Kruse BD,Unterer S,Horlacher K,Sauter-Louis C,Hartmann K.Prognostic factors in cats with feline panleukopenia.J Vet Intern Med. 2010;24:1271-1276.
8. Reese MJ,Patterson EV,Tucker SJ,Dubovi EJ,Davis RD,Crawford PC, et al.Effects of anesthesia and surgery on serologic responses to vaccination in kittens.J Am Vet Med Assoc. 2008;233:116-121.
9. DiGangi BA,Gray LK,Levy JK,Dubovi EJ,Tucker SJ.Detection of protective antibody titers against feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus in shelter cats using a point-of-care ELISA.J Feline Med Surg. 2011;13:912-918.
10. Dawson S,Willoughby K,Gaskell RM,Wood G,Chalmers WS.A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.J Feline Med Surg. 2001;3:17-22.
11. Jakel V,Cussler K,Hanschmann KM,Truyen U,Konig M,Kamphuis E, et al.Vaccination against feline panleukopenia: implications from a field study in kittens.BMC Vet Res. 2012;8:62.
12. Hofmann-Lehmann R,Holznagel E,Aubert A,Ossent P,Reinacher M,Lutz H.Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.Vet Immunol Immunopathol. 1995;46:127-137.
13. Hoover EA,Mullins JI,Chu HJ,Wasmoen TL.Efficacy of an inactivated feline leukemia virus vaccine.AIDS Res Hum Retroviruses. 1996;12:379-383.
14. Harbour DA,Gunn-Moore DA,Gruffydd-Jones TJ,Caney SM,Bradshaw J,Jarrett O, et al.Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine.Vaccine. 2002;20:2866-2872.
15. Jirjis F,Davis T,Lane J,Carritt K,Sweeney D,Williams J, et al.Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.Vet Ther. 2010;11:E1-6.
16. Lutz H,Addie D,Belak S,Boucraut-Baralon C,Egberink H,Frymus T, et al.Feline leukaemia ABCD guidelines on prevention and management.J Feline Med Surg. 2009;11:565-574.
17. Hoover EA,Olsen RG,Hardy WD,Schaller JP,Mathes LE.Feline leukemia virus infection: age-related variation in response of cats to experimental infection.J Natl Cancer Inst. 1976;57:365-369.
18. Levy J,Crawford C,Hartmann K,Hofmann-Lehmann R,Little S,Sundahl E, et al.2008 American Association of Feline Practitioners' feline retrovirus management guidelines.J Feline Med Surg. 2008;10:300-316.
19. Sharp NJ,Davis BJ,Guy JS,Cullen JM,Steingold SF,Kornegay JN.Hydranencephaly and cerebellar hypoplasia in two kittens attributed to intrauterine parvovirus infection.J Comp Pathol. 1999;121:39-53.
20. Westhoff D,Orveillon FX,Farnow D,Klös MC,Elbers K.Safety of a non-adjuvanted therapeutic vaccine for the treatment of feline dermatophytosis.Vet Rec. 2010;167:899-903.
21. Westhoff DK,Kloes M-C,Orveillon FX,Farnow D,Elbers K,Mueller RS.Treatment of feline dermatophytosis with an inactivated fungal vaccine.Open Mycol J. 2010;4:10-17.
22. DiGangi BA,Levy JK,Griffin B,Reese MJ,Dingman PA,Tucker SJ, et al.Effects of maternally-derived antibodies on serologic responses to vaccination in kittens.J Feline Med Surg. 2012;14:118-123.
23. Brun A,Chappuis G,Precausta P,Terre J.Immunisation against panleukopenia: early development of immunity.Comp Immunol Microbiol Infect Dis. 1979;1:335-339.
24. Poulet H,Jas D,Lemeter C,Coupier C,Brunet S.Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: relation between in vitro cross-neutralization and heterologous protection in vivo.Vaccine. 2008;26:3647-3654.
25. Huang C,Hess J,Gill M,Hustead D.A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.J Feline Med Surg. 2010;12:129-137.
26. McManus CM,Levy JK,Andersen LA, et al.Prevalence of upper respiratory pathogens in four management models for unowned cats in the Southeast United States [abstract].J Vet Intern Med. 2011;25:707.
27. Radford AD,Addie D,Belak S,Boucraut-Baralon C,Egberink H,Frymus T, et al.Feline calicivirus infection: ABCD guidelines on prevention and management.J Feline Med Surg. 2009;11:556-564.
28. Cocker FM,Newby TJ,Gaskell RM,Evans PA,Gaskell CJ,Stokes CR, et al.Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1.Res Vet Sci. 1986;41:323-330.
29. Edinboro C,Janowitz L,Guptill-Yoran L,Glickman RT.A clinical trial of intranasal and subcutaneous vaccines to prevent upper respiratory infection in cats at an animal shelter.Feline Pract. 1999;27:7-11.
30. Newbury SP.A placebo controlled field trial of an intranasal vaccine for feline calicivirus and feline herpesvirus to prevent clinical signs of feline infectious respiratory disease complex in an animal shelter. Proceedings of the 88th Conference of Research Workers in Animal Diseases; 2007; 2007.
31. Bannasch M,Foley J.Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters.J Feline Med Surg. 2005;7:109-119.
32. Veir JK,Ruch-Gallie R,Spindel ME,Lappin MR.Prevalence of selected infectious organisms and comparison of two anatomic sampling sites in shelter cats with upper respiratory tract disease.J Feline Med Surg. 2008;10:551-557.
33. Binns S,Dawson S,Speakman A,Lappin MR.Prevalence and risk factors for feline Bordetella bronchiseptica infection.Vet Rec. 1999;:144.
34. Spindel ME,Veir JK,Radecki SV,Lappin MR.Evaluation of pradofloxacin for the treatment of feline rhinitis.J Feline Med Surg. 2008;10:472-479.
35. Fischer SM,Quest CM,Dubovi EJ,Davis RD,Tucker SJ,Friary JA, et al.Response of feral cats to vaccination at the time of neutering.J Am Vet Med Assoc. 2007;230:52-58.
36. Rochlitz I.Recommendations for the housing of cats in the home, in catteries and animal shelters, in laboratories and in veterinary surgeries.J Feline Med Surg. 1999;1:181-191.
37. Lalonde J,Heron W,Gourkow N,Joosting N,Litman M,Bolinder A, et al.A code of practice for Canadian cattery operations. 2009;:.
38. Povey RC,Wilson MR.A comparison of inactivated feline viral rhinotracheitis and feline caliciviral disease vaccines with live-modified viral vaccines.Feline Pract. 1978;8:35-42.
39. Iglauer F,Gartner K,Morstedt R.Maternal immunization against feline viral rhinopneumonitis with a booster dose during pregnancy - a retrospective clinical study.Kleintierpraxis. 1989;34:243-249.
40. Tizard I,Ni Y.Use of serologic testing to assess immune status of companion animals.J Am Vet Med Assoc. 1998;213:54-60.
41. Schultz RD,Ford RB,Olson J,Scott F.Titer testing and vaccination: a new look at traditional practices.Vet Med. 2002;97:1-13.
42. Day MJ.Vaccine side effects: fact and fiction.Vet Microbiol. 2006;117:51-58.
43. Moore GE,Hogenesch H.Adverse vaccinal events in dogs and cats.Vet Clin North Am Small Anim Pract. 2010;40:393-407.
44. Gaskell R,Gettinby G,Graham S,Skilton D.Veterinary Products Committee working group report on feline and canine vaccination.Vet Rec. 2002;150:126-134.
45. Gobar G,Kass P.World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats.J Am Vet Med Assoc. 2002;220:1477-1482.
46. Clark N,Kushner NN,Barrett CB,Kensil CR,Salsbury D,Cotter S.Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection.J Am Vet Med Assoc. 1991;199:1433-1443.
47. Hines DL,Cutting JA,Dietrich DL,Walsh JA.Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.J Am Vet Med Assoc. 1991;199:1428-1430.
48. Starr RM.Reaction rate in cats vaccinated with a new controlled-titer feline panleukopenia-rhinotracheitis-calicivirus-Chlamydia psittaci vaccine.Cornell Vet. 1993;83:311-323.
49. Davis-Wurzler GM.Current vaccination strategies in puppies and kittens.Vet Clin North Am Small Anim Pract. 2006;36:607 vii-640.
50. Bennett D,Gaskell RM,Mills A,Knowles J,Carter S,McArdle F.Detection of feline calicivirus antigens in the joints of infected cats.Vet Rec. 1989;124:329-332.
51. Dawson S,Bennett D,Carter SD,Bennett M,Meanger J,Turner PC, et al.Acute arthritis of cats associated with feline calicivirus infection.Res Vet Sci. 1994;56:133-143.
52. Kass PH,Barnes WG,Spangler WL,Chomel BB,Culbertson MR.Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats.J Am Vet Med Assoc. 1993;203:396-405.
53. Hendrick M.Historical review and current knowledge of risk factors involved in feline vaccine-associated sarcomas.J Am Vet Med Assoc. 1998;213:1422-1423.
54. Lester S,Clemett T,Burt A.Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993).J Am Anim Hosp Assoc. 1996;32:91-95.
55. Macy D,Hendrick M.The potential role of inflammation in the development of postvaccinal sarcomas in cats.Vet Clin North Am Small Anim Pract. 1996;26:103-109.
56. Kass PH,Spangler WL,Hendrick MJ,McGill LD,Esplin DG,Lester S, et al.Multicenter case-control study of risk factors associated with development of vaccine-associated sarcomas in cats.J Am Vet Med Assoc. 2003;223:1283-1292.
57. Hendrick MJ,Brooks JJ.Postvaccinal sarcomas in the cat: histology and immunohistochemistry.Vet Pathol. 1994;31:126-129.
58. Wilcock B,Wilcock A,Bottoms K.Feline postvaccinal sarcoma: 20 years later.Can Vet J. 2012;53:430-434.
59. Srivastav A,Kass PH,McGill LD,Farver TB,Kent MS.Comparative vaccine-specific and other injectable-specific risks of injection-site sarcomas in cats.J Am Vet Med Assoc. 2012;241:595-602.
60. Martano M,Morello E,Buracco P.Feline injection-site sarcoma: past, present and future perspectives.Vet J. 2011;188:136-141.
61. Day MJ,Schoon HA,Magnol JP,Saik J,Devauchelle P,Truyen U, et al.A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines.Vaccine. 2007;25:4073-4084.
62. Day MJ,Horzinek MC,Schultz RD.Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA).J Small Anim Pract. 2007;48:528-541.
63. Morrison WB,Starr RM.Vaccine-associated feline sarcomas.J Am Vet Med Assoc. 2001;218:697-702.
64. Woodward KN.Origins of injection-site sarcomas in cats: the possible role of chronic inflammation - a review.ISRN Vet Sci. 2011;2011:.
65. McEntee M,Page R.Feline vaccine-associated sarcomas.J Vet Intern Med. 2001;15:176-182.
66. Day MJ,Horzinek MC,Schultz RD.WSAVA guidelines for the vaccination of dogs and cats.J Small Anim Pract. 2010;51:338-356.
67. Kirpensteijn J.Feline injection site-associated sarcoma: is it a reason to critically evaluate our vaccination policies?.Vet Microbiol. 2006;117:59-65.
68. Spickler A,Roth J.Adjuvants in veterinary vaccines: modes of action and adverse effects.J Vet Intern Med. 2003;17:273-281.
69. Davis KM,Hardie EM,Lascelles BD,Hansen B.Feline fibrosarcoma: perioperative management.Compend Contin Educ Vet. 2007;29:712 716 722-714 720 729.
70. Davis KM,Hardie EM,Martin FR,Zhu J,Brownie C.Correlation between perioperative factors and successful outcome in fibrosarcoma resection in cats.Vet Rec. 2007;161:199-200.
71. Martano M,Morello E,Ughetto M,Iussich S,Petterino C,Cascio P, et al.Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases.Vet J. 2005;170:84-90.
72. Bergman P.Recent advances in the treatment of feline vaccine-associated sarcomas.Adv Small Anim Med Surg. 2000;13:1-2.
73. Cohen M,Wright J,Brawner W,Smith AN,Henderson R,Behrend EN.Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000).J Am Vet Med Assoc. 2001;219:1582-1589.
74. Hershey A,Sorenmo K,Hendrick M,Shofer FS,Vail DM.Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996).J Am Vet Med Assoc. 2000;216:58-61.
75. Phelps HA,Kuntz CA,Milner RJ,Powers BE,Bacon NJ.Radical excision with five-centimeter margins for treatment of feline injection-site sarcomas: 91 cases (1998-2002).J Am Vet Med Assoc. 2011;239:97-106.
76. Shaw SC,Kent MS,Gordon IK,Collins CJ,Greasby TA,Beckett LA, et al.Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006).J Am Vet Med Assoc. 2009;234:376-380.